Breaking News on Contract Research, Manufacturing & Clinical Trials

Latest news headlines

Products

Suppliers

Akela plans CMO buys after exiting development project

10-Aug-2011 - Akela Pharma is focusing on its CMO and expanding it through acquisitions after its partner exited their drug development programme.

apceth gets the go-ahead for somatic cell line production

09-Aug-2011 - Contract manufacturing of somatic cell line therapies is to begin at apceth after the German company received a license.

Outsourcing brings Neovacs to cusp of Ph III partnership

09-Aug-2011 - Neovacs is looking to partner for late stage development after using its outsourced model to bring multiple products to Phase II.

DSM seeks CMO partner to diversify beyond big pharma

04-Aug-2011 - DSM wants to form a CMO joint venture to become less reliant on big pharma clients and revive the flagging business unit.

News in brief

Pii adds trial scale HME capacity

28-Jul-2011 - Pharmaceutics International (Pii) has expanded its range of formulation and process development services with the addition of bioavailability boosting hot-melt extrusion (HME) capabilities.

Alkermes - EDT merger to spark consolidation & strategic shift

19-Jul-2011 - EDT will accelerate its shift to proprietary products and consolidate to save $20m when its takeover by Alkermes closes.

Phillips to enter EU primary packaging with Medisize buy

12-Jul-2011 - Phillips Plastics is to expand into Europe and add primary packaging contract manufacturing capabilities by acquiring Medisize.

Sanofi selling CMO & in-house production site to Valeant

11-Jul-2011 - Valeant Pharmaceuticals is to buy a dermatology unit, including CMO and in-house production assets, from Sanofi.

New synthetic cell membranes set to cut time and costs

11-Jul-2011 - Costly and time consuming drug screening could soon be a thing of the past thanks to new easy-bake synthetic cell membranes made at the Institute of Materials Research and Engineering (IMRE).

News in brief

Amarin calls on Banner, Catalent, Chemport and Equateq for AMR101 supply

31-May-2011 - Amarin has turned to CMOs to support the commercial launch of its prescription grade omega-3 fatty acid drug AMR101 for high triglyceride levels.

Alkermes' loss deepens in FY 2011 but firm upbeat on revs and EDT plans

19-May-2011 - Alkermes saw losses increase in fiscal 2011 but has issued an upbeat outlook on higher revenues, portfolio expansion and impending acquisition of Elan Drug Technologies (EDT).

News in brief

Oynx wins API contract with Cancer Research UK

10-May-2011 - CMO Onyx Scientific will make a new anticancer API under a new deal with charity Cancer Research UK.

Elan sells EDT unit to Alkermes

09-May-2011 - Elan will sell its delivery technology unit, EDT, to Alkermes in a deal that brings to an end the Irish drugmakers’ long search for a buyer.

News in brief

Pharmaceutics International expands manufacturing capabilities

02-May-2011 - US-based Pharmaceutics International, a contract development and manufacturing organization has added an MG2 G140 capsule filler to its oral manufacturing area.

Packaging components drive solid Q1 growth at West

02-May-2011 - Strong first quarter performance at the packaging unit helped West beat expectations but there were CZ and Delivery Systems disappointments.

Mitsui to buy MBS to bolster CMO and strengthen in China

26-Apr-2011 - Mitsui is to boost its intermediate, API and finished product CMO business and expand in China by buying MBS.

EDT sales drop as generic competition begins to bite

21-Apr-2011 - Elan Drug Technologies’ (EDT) revenues dropped in the first quarter as generic competition wiped out Skelaxin (metaxalone) earnings.

Round up of M&A in pharma contract services

19-Apr-2011 - Outsourcing-Pharma presents a round up of contract services merger and acquisition activity, including deals at Evotec, Vyteris and Avantium Pharma.

EDT talks about the contract manufacturing market at Interphex

14-Apr-2011 - Pharma industry demand for outsourced manufacturing is growing and will favour larger contracting players according to Elan Drug Technologies (EDT).

West says Crystal Zenith syringe is solution to pharmas' glass delamination problem

14-Apr-2011 - West Pharmaceutical Services is preparing to increase its manufacturing capacity in response to an increased demand for its Daikyo Crystal Zenith 1mL syringe system.

Bend Research receives polymer additives patent

11-Apr-2011 - Bend Research, the Oregon US-based drug manufacturer, has received a new US patent covering the use of polymer additives to help increase the efficacy of low-solubility drugs.

CMO consolidation will support 100% virtual supply chains

23-Feb-2011 - Consolidation of CMOs will support use of completely outsourced production and distribution networks in the near future.

News in brief

BNC adds new consultants in China

17-Feb-2011 - BioNano Consulting (BNC) has signed up two new experts as part of an effort to build its presence in China.

PSI partners with Horiba to access characterisation tools

08-Feb-2011 - CRO Particle Sciences (PSI) has formed a strategic partnership with Horiba to use its characterisation tools and service its clients.

Oxford Biomedica buys UK plant to cut reliance on CMO

01-Feb-2011 - Oxford Biomedica has bought RecipharmCobra Biologics’ manufacturing facility in Oxford, UK, to reduce its reliance on third-party production of its gene delivery technology.